fulvestrant has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Reddy, K; Smith, D; Wang, X; Wong, C | 1 |
| Cai, X; Chai, R; Chen, J; Chen, L; Gong, X; Gu, J; Liu, Y; Mo, L; Thiery, JP; Wang, X; Wu, C; Wu, X; Yu, S; Yu, Z; Zhang, J; Zhu, T | 1 |
1 review(s) available for fulvestrant and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
| Article | Year |
|---|---|
AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies.
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Letrozole; Nitriles; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Estrogen; Transcriptional Activation; Triazoles | 2012 |
1 other study(ies) available for fulvestrant and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
| Article | Year |
|---|---|
Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer.
Topics: Acetylation; Anilides; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Survival; Estradiol; Female; Fulvestrant; Histone Deacetylase 6; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Immunohistochemistry; Lactams, Macrocyclic; Mice; Tamoxifen; Triple Negative Breast Neoplasms | 2017 |